Related Experiment Video
Updated: Oct 21, 2025

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Risk factors for left atrial thrombus or spontaneous echo contrast in non-valvular atrial fibrillation patients with
Jindong Chen1, Mengmeng Zhou1, Hao Wang1
1Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
Insights
Elevated fibrinogen and enlarged left atrium (LA) are key risk factors for left atrial thrombus (LAT) or spontaneous echo contrast (LASEC) in non-valvular atrial fibrillation (NVAF) patients with low CHA₂DS₂-VASc scores. Incorporating these factors improves risk prediction accuracy.
Area of Science:
- Cardiology
- Internal Medicine
- Thrombosis Research
Background:
- Left atrial thrombus (LAT) and spontaneous echo contrast (LASEC) are complications in non-valvular atrial fibrillation (NVAF).
- Existing risk stratification scores like CHA₂DS₂-VASc may underestimate risk in NVAF patients with low scores.
- Limited data exists on specific risk factors for LAT/LASEC in this low-risk subgroup.
Purpose of the Study:
- To identify and evaluate risk factors for LAT/LASEC in NVAF patients with low CHA₂DS₂-VASc scores.
- To assess the predictive value of novel risk factors when added to the CHA₂DS₂-VASc score.
Main Methods:
- Retrospective observational study analyzing transesophageal echocardiography (TEE) data from 3056 NVAF patients with low CHA₂DS₂-VASc scores.
- Binary logistic regression and propensity score matching (PSM) were used to identify independent risk factors.
- Receiver operating characteristic (ROC) analysis evaluated the enhanced predictive model.
Main Results:
- Elevated fibrinogen levels and enlarged left atrium (LA) were identified as significant risk factors for LAT/LASEC.
- PSM confirmed fibrinogen and LA size as independent predictors.
- Adding fibrinogen and left atrial diameter (LAD) to the CHA₂DS₂-VASc score significantly improved LAT/LASEC prediction accuracy (AUC difference = 0.241).
Conclusions:
- Elevated fibrinogen and enlarged LA are independent risk factors for LAT/LASEC in low-risk NVAF patients.
- Integrating fibrinogen and LAD into risk assessment models can enhance the prediction of LAT/LASEC.
- Further validation studies are recommended to confirm these findings.
Objective:
Risk factors of left atrial thrombus (LAT) or spontaneous echo contrast (LASEC) in non-valvular atrial fibrillation (NVAF) had been reported. However, information in the subgroup of NVAF patients with low CHA2DS2-VASc scores was limited. Here, we evaluated the risk factors of LAT/LASEC in NVAF patients with low CHA2DS2-VASc scores.
Methods:
Transesophageal echocardiography (TEE) file of NVAF patients with low CHA2DS2-VASc scores was reviewed (between June 2009 and Feb 2019) in this retrospective observational study. Binary logistic regression analysis was performed to identify risk factors other than the CHA2DS2-VASc score. Propensity score matching (PSM) was used to further evaluate independent risk markers for LAT/LASEC. The newly discovered factors were added to the CHA2DS2-VASc score, and receiver operating characteristic analysis was used to evaluate the ability of the model to predict LAT/LASEC.
Results:
TEE files of 3056 NVAF patients with low CHA2DS2-VASc scores were reviewed. Regression analysis revealed elevated fibrinogen and enlarged left atrium (LA) were risk factors for LAT/LASEC. Further PSM analysis confirmed that elevated fibrinogen and enlarged LA were independent risk factors for LAT/LASEC. After including fibrinogen and left atrial diameter (LAD), the CHA2DS2-VASc score was more accurate for LAT/LASEC prediction in NVAF patients with low CHA2DS2-VASc scores (area under the curve difference is 0.241, 95% confidence interval (CI) 0.188-0.294, Z = 8.890, P < 0.0001).
Conclusions:
Elevated fibrinogen and enlarged LA were independent risk factors for LAT/LASEC in NVAF patients with low CHA2DS2-VASc scores. Taking fibrinogen and LAD into consideration may help improve LAT/LASEC risk evaluation, which warrants further validation studies.
Related Concept Videos
Venous Thrombosis I: Introduction
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Imaging Studies for Cardiovascular System II:Types of Echocardiography
Types of Echocardiography
Transthoracic Echocardiography (TTE)
TTE is the most common type of echocardiogram which involves placing a transducer on the patient's chest, emitting sound waves to create heart images. TTE is invaluable for evaluating the heart's size, structure, and motion, making it particularly useful for...
Acute Coronary Syndrome III: Diagnostic Studies
Dysrhythmias V: Evaluating Dysrhythmias
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

